Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Revolution Biosciences
AddedFeb 18, 2024
UpdatedJun 18, 2026
Revolution Biosciences

Revolution Biosciences

Angel

Revolution BioSciences: Early-stage drug discovery firm offering bioanalytical services & MALDI MS products.

HQ
Norwell, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Revolution BioSciences, founded in the greater Boston area, is an early-stage biopharmaceutical company dedicated to advancing drug discovery. The company's core mission is to accelerate the development of novel therapeutics through innovative bioanalytical services and cutting-edge MALDI TOF Mass Spectrometry (MS) products. Their offerings include assay development, high throughput screening, and lead optimization, catering primarily to the pharmaceutical and biotechnology sectors.

The team at Revolution BioSciences includes seasoned experts with extensive experience in the BioPharma industry. The company operates from a state-of-the-art laboratory, enabling them to deliver high-quality Contract Research Organization (CRO) services. Notable achievements include the development of robust and novel assays that have significantly impacted drug discovery processes. Through their specialized services and consulting expertise, Revolution BioSciences has established itself as a key player in the early-stage drug discovery market.

Revolution Biosciences - Similar Companies

Accium BioSciences logo

Accium BioSciences

LiVeritas Biosciences logo

LiVeritas Biosciences

liveritas.bio

BioAnalytics logo

BioAnalytics

BioAnalytix logo

BioAnalytix

bioanalytixinc.com

Revvity logo

Revvity

RedShift BioAnalytics logo

RedShift BioAnalytics

redshiftbio.com

Bioinformatics logo

Bioinformatics

bioinfoinc.com

ReviveMed logo

ReviveMed

RevMAb Biosciences logo

RevMAb Biosciences

revmab.com

Amador Bioscience logo

Amador Bioscience

Andson Biotech logo

Andson Biotech

andsonbiotech.com

Sapient logo

Sapient

sapient.bio

Transition Bio logo

Transition Bio

transitionbio.com

Meadowhawk Biolabs logo

Meadowhawk Biolabs

QuantumBio logo

QuantumBio

quantumbioinc.com

Revolution Biosciences - Quick Facts

Who are Revolution Biosciences' competitors?

Companies similar to Revolution Biosciences include Accium BioSciences, LiVeritas Biosciences, BioAnalytics and BioAnalytix.

When was Revolution Biosciences founded?

Revolution Biosciences was founded in 2015.

Where is Revolution Biosciences' headquarters located?

Revolution Biosciences' headquarters is located in Norwell, MA, US.

When was Revolution Biosciences' last funding round?

Revolution Biosciences' most recent funding round was for $195k (USD) in December 2015.

How much has Revolution Biosciences raised to-date?

As of Dec 16, 2015, Revolution Biosciences has raised a total of $195k (USD).

How many employees does Revolution Biosciences have?

Revolution Biosciences has 2 employees as of Feb 4, 2024.

Revolution Biosciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Enterprise
Main Product
  • Bioanalytical Services
  • Drug Discovery
Tags
  • Biotech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software